Prudent Man Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $784K | Buy |
1,933
+473
| +32% | +$192K | 0.25% | 92 |
|
|
2025
Q1 | $726K | Buy |
1,460
+32
| +2% | +$15.9K | 0.26% | 88 |
|
|
2024
Q4 | $743K | Sell |
1,428
-128
| -8% | -$66.6K | 0.27% | 80 |
|
|
2024
Q3 | $962K | Sell |
1,556
-93
| -6% | -$57.5K | 0.32% | 74 |
|
|
2024
Q2 | $912K | Buy |
1,649
+61
| +4% | +$33.7K | 0.32% | 73 |
|
|
2024
Q1 | $923K | Sell |
1,588
-1,551
| -49% | -$901K | 0.35% | 69 |
|
|
2023
Q4 | $1.67M | Sell |
3,139
-127
| -4% | -$67.4K | 0.62% | 26 |
|
|
2023
Q3 | $1.65M | Sell |
3,266
-262
| -7% | -$133K | 0.66% | 21 |
|
|
2023
Q2 | $1.84M | Sell |
3,528
-63
| -2% | -$32.9K | 0.69% | 21 |
|
|
2023
Q1 | $2.07M | Sell |
3,591
-48
| -1% | -$27.7K | 0.81% | 17 |
|
|
2022
Q4 | $2M | Buy |
3,639
+531
| +17% | +$292K | 0.81% | 16 |
|
|
2022
Q3 | $1.58M | Sell |
3,108
-220
| -7% | -$112K | 0.75% | 19 |
|
|
2022
Q2 | $1.81M | Buy |
3,328
+302
| +10% | +$164K | 0.84% | 16 |
|
|
2022
Q1 | $1.79M | Sell |
3,026
-73
| -2% | -$43.1K | 0.72% | 20 |
|
|
2021
Q4 | $2.07M | Sell |
3,099
-351
| -10% | -$234K | 0.79% | 19 |
|
|
2021
Q3 | $1.97M | Sell |
3,450
-56
| -2% | -$32K | 0.75% | 20 |
|
|
2021
Q2 | $1.77M | Buy |
3,506
+211
| +6% | +$106K | 0.68% | 23 |
|
|
2021
Q1 | $1.5M | Buy |
3,295
+125
| +4% | +$57.1K | 0.63% | 29 |
|
|
2020
Q4 | $14.8M | Sell |
3,170
-102
| -3% | -$475K | 6.19% | 3 |
|
|
2020
Q3 | $1.45M | Sell |
3,272
-60
| -2% | -$26.5K | 0.77% | 21 |
|
|
2020
Q2 | $1.21M | Buy |
+3,332
| New | +$1.21M | 1.07% | 19 |
|